Synchron: Undisclosed valuation, IPO Readiness 51, Series D. Developing the Stentrode — the world's only brain-computer interface that requires no open-brain surgery, enab. Track live on The IPO Stack.
Developing the Stentrode — the world's only brain-computer interface that requires no open-brain surgery, enabling people with severe paralysis to control digital devices with their thoughts.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Synchron IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Synchron has not publicly announced IPO plans. Track TechStackIPO for the latest signals and subscribe to The IPO Stack for weekly updates.
Synchron is valued at Undisclosed as of the most recent funding round. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Synchron shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Synchron scores 51/100 (Grade: D) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Synchron has raised $345M in total venture capital and private equity funding, with backing from Double Point Ventures, ARCH Venture Partners, Private Investors.
Synchron's notable investors include Double Point Ventures, ARCH Venture Partners, Private Investors. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Synchron is a Medical Technology company. Developing the Stentrode — the world's only brain-computer interface that requires no open-brain surgery, enabling peopl.